The global Brain Tumor Diagnosis and Therapeutics market is projected to grow from US$ 2674 million in 2024 to US$ 4685.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.

Brain Tumor Diagnosis and Therapeutics Market

Brain tumors are treated with surgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.

Market Analysis and Insights: Global Brain Tumor Diagnosis and Therapeutics Market

The US & Canada market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Brain Tumor Diagnosis and Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Brain Tumor Diagnosis and Therapeutics include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Brain Tumor Diagnosis and Therapeutics is widely used in various fields, such as Surgery, Radiation Therapy, Chemotherapy and Immunotherapy, etc. Surgery provides greatest supports to the Brain Tumor Diagnosis and Therapeutics industry development. In 2023, global % revenue of Brain Tumor Diagnosis and Therapeutics went into Surgery filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Brain Tumor Diagnosis and Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Brain Tumor Diagnosis and Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Brain Tumor Diagnosis and Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Brain Tumor Diagnosis and Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Brain Tumor Diagnosis and Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Brain Tumor Diagnosis and Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Brain Tumor Diagnosis and Therapeutics Market Report

Report Metric	Details
Report Name	Brain Tumor Diagnosis and Therapeutics Market
Accounted market size in 2024	US$ 2674 in million
Forecasted market size in 2030	US$ 4685.7 million
CAGR	9.8
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	MRI CT Scan Tissue Sampling PET-CT Scan Cerebral Arteriogram Lumbar Puncture Molecular Testing EEG
Segment by Application	Surgery Radiation Therapy Chemotherapy Immunotherapy Targeted Therapy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co., AstraZeneca, Bristol Myer Squibb, Novartis, Roche Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Brain Tumor Diagnosis and Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Tumor Diagnosis and Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain Tumor Diagnosis and Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Brain Tumor Diagnosis and Therapeutics Market growing?

Ans: The Brain Tumor Diagnosis and Therapeutics Market witnessing a CAGR of 9.8 during the forecast period 2024-2030.

What is the Brain Tumor Diagnosis and Therapeutics Market size in 2030?

Ans: The Brain Tumor Diagnosis and Therapeutics Market size in 2030 will be US$ 4685.7 million.

Who are the main players in the Brain Tumor Diagnosis and Therapeutics Market report?

Ans: The main players in the Brain Tumor Diagnosis and Therapeutics Market are GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co., AstraZeneca, Bristol Myer Squibb, Novartis, Roche Diagnostics

What are the Application segmentation covered in the Brain Tumor Diagnosis and Therapeutics Market report?

Ans: The Applications covered in the Brain Tumor Diagnosis and Therapeutics Market report are Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy

What are the Type segmentation covered in the Brain Tumor Diagnosis and Therapeutics Market report?

Ans: The Types covered in the Brain Tumor Diagnosis and Therapeutics Market report are MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, EEG

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 MRI

1.2.3 CT Scan

1.2.4 Tissue Sampling

1.2.5 PET-CT Scan

1.2.6 Cerebral Arteriogram

1.2.7 Lumbar Puncture

1.2.8 Molecular Testing

1.2.9 EEG

1.3 Market by Application

1.3.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Surgery

1.3.3 Radiation Therapy

1.3.4 Chemotherapy

1.3.5 Immunotherapy

1.3.6 Targeted Therapy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Brain Tumor Diagnosis and Therapeutics Market Perspective (2019-2030)

2.2 Global Brain Tumor Diagnosis and Therapeutics Growth Trends by Region

2.2.1 Brain Tumor Diagnosis and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Brain Tumor Diagnosis and Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Brain Tumor Diagnosis and Therapeutics Market Dynamics

2.3.1 Brain Tumor Diagnosis and Therapeutics Industry Trends

2.3.2 Brain Tumor Diagnosis and Therapeutics Market Drivers

2.3.3 Brain Tumor Diagnosis and Therapeutics Market Challenges

2.3.4 Brain Tumor Diagnosis and Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Brain Tumor Diagnosis and Therapeutics by Players

3.1.1 Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Brain Tumor Diagnosis and Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio

3.4.1 Global Brain Tumor Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Therapeutics Revenue in 2023

3.5 Global Key Players of Brain Tumor Diagnosis and Therapeutics Head office and Area Served

3.6 Global Key Players of Brain Tumor Diagnosis and Therapeutics, Product and Application

3.7 Global Key Players of Brain Tumor Diagnosis and Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Type

4.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030)

5 Brain Tumor Diagnosis and Therapeutics Breakdown Data by Application

5.1 Global Brain Tumor Diagnosis and Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)

6.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type

6.2.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

6.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application

6.3.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

6.4 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country

6.4.1 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)

7.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type

7.2.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

7.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application

7.3.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

7.4 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country

7.4.1 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)

8.2 China Brain Tumor Diagnosis and Therapeutics Market Size by Type

8.2.1 China Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024)

8.2.2 China Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030)

8.2.3 China Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

8.3 China Brain Tumor Diagnosis and Therapeutics Market Size by Application

8.3.1 China Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024)

8.3.2 China Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030)

8.3.3 China Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)

9.2 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Type

9.2.1 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

9.3 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Application

9.3.1 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

9.4 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Region

9.4.1 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Brain Tumor Diagnosis and Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Details

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Introduction

11.1.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.1.5 GE Healthcare Recent Developments

11.2 Hitachi

11.2.1 Hitachi Company Details

11.2.2 Hitachi Business Overview

11.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Introduction

11.2.4 Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.2.5 Hitachi Recent Developments

11.3 Philips Healthcare

11.3.1 Philips Healthcare Company Details

11.3.2 Philips Healthcare Business Overview

11.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Introduction

11.3.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.3.5 Philips Healthcare Recent Developments

11.4 Siemens Healthineers

11.4.1 Siemens Healthineers Company Details

11.4.2 Siemens Healthineers Business Overview

11.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Introduction

11.4.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.4.5 Siemens Healthineers Recent Developments

11.5 Toshiba Corporation

11.5.1 Toshiba Corporation Company Details

11.5.2 Toshiba Corporation Business Overview

11.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Introduction

11.5.4 Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.5.5 Toshiba Corporation Recent Developments

11.6 Fujifilm Corporation

11.6.1 Fujifilm Corporation Company Details

11.6.2 Fujifilm Corporation Business Overview

11.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Introduction

11.6.4 Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.6.5 Fujifilm Corporation Recent Developments

11.7 Shimadzu Corporation

11.7.1 Shimadzu Corporation Company Details

11.7.2 Shimadzu Corporation Business Overview

11.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Introduction

11.7.4 Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.7.5 Shimadzu Corporation Recent Developments

11.8 Merck & Co.

11.8.1 Merck & Co. Company Details

11.8.2 Merck & Co. Business Overview

11.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Introduction

11.8.4 Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.8.5 Merck & Co. Recent Developments

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Introduction

11.9.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.9.5 AstraZeneca Recent Developments

11.10 Bristol Myer Squibb

11.10.1 Bristol Myer Squibb Company Details

11.10.2 Bristol Myer Squibb Business Overview

11.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Introduction

11.10.4 Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.10.5 Bristol Myer Squibb Recent Developments

11.11 Novartis

11.11.1 Novartis Company Details

11.11.2 Novartis Business Overview

11.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Introduction

11.11.4 Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.11.5 Novartis Recent Developments

11.12 Roche Diagnostics

11.12.1 Roche Diagnostics Company Details

11.12.2 Roche Diagnostics Business Overview

11.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Introduction

11.12.4 Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

11.12.5 Roche Diagnostics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of MRI

Table 3. Key Players of CT Scan

Table 4. Key Players of Tissue Sampling

Table 5. Key Players of PET-CT Scan

Table 6. Key Players of Cerebral Arteriogram

Table 7. Key Players of Lumbar Puncture

Table 8. Key Players of Molecular Testing

Table 9. Key Players of EEG

Table 10. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 11. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2019-2024)

Table 14. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region (2025-2030)

Table 16. Brain Tumor Diagnosis and Therapeutics Market Trends

Table 17. Brain Tumor Diagnosis and Therapeutics Market Drivers

Table 18. Brain Tumor Diagnosis and Therapeutics Market Challenges

Table 19. Brain Tumor Diagnosis and Therapeutics Market Restraints

Table 20. Global Brain Tumor Diagnosis and Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Players (2019-2024)

Table 22. Global Top Brain Tumor Diagnosis and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2023)

Table 23. Global Brain Tumor Diagnosis and Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 24. Global 5 Largest Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 25. Global Key Players of Brain Tumor Diagnosis and Therapeutics, Headquarters and Area Served

Table 26. Global Key Players of Brain Tumor Diagnosis and Therapeutics, Product and Application

Table 27. Global Key Players of Brain Tumor Diagnosis and Therapeutics, Product and Application

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2019-2024)

Table 31. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Type (2025-2030)

Table 33. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Application (2019-2024)

Table 35. Global Brain Tumor Diagnosis and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Application (2025-2030)

Table 37. North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 38. North America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 39. North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 40. North America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 41. North America Brain Tumor Diagnosis and Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. North America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 45. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 46. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 47. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 48. Europe Brain Tumor Diagnosis and Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 50. Europe Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 51. China Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 52. China Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 53. China Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 54. China Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 56. Asia Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 57. Asia Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 58. Asia Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 59. Asia Brain Tumor Diagnosis and Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 60. Asia Brain Tumor Diagnosis and Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 61. Asia Brain Tumor Diagnosis and Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 67. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 68. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 69. GE Healthcare Company Details

Table 70. GE Healthcare Business Overview

Table 71. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product

Table 72. GE Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 73. GE Healthcare Recent Developments

Table 74. Hitachi Company Details

Table 75. Hitachi Business Overview

Table 76. Hitachi Brain Tumor Diagnosis and Therapeutics Product

Table 77. Hitachi Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Hitachi Recent Developments

Table 79. Philips Healthcare Company Details

Table 80. Philips Healthcare Business Overview

Table 81. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product

Table 82. Philips Healthcare Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Philips Healthcare Recent Developments

Table 84. Siemens Healthineers Company Details

Table 85. Siemens Healthineers Business Overview

Table 86. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product

Table 87. Siemens Healthineers Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Siemens Healthineers Recent Developments

Table 89. Toshiba Corporation Company Details

Table 90. Toshiba Corporation Business Overview

Table 91. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product

Table 92. Toshiba Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Toshiba Corporation Recent Developments

Table 94. Fujifilm Corporation Company Details

Table 95. Fujifilm Corporation Business Overview

Table 96. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product

Table 97. Fujifilm Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Fujifilm Corporation Recent Developments

Table 99. Shimadzu Corporation Company Details

Table 100. Shimadzu Corporation Business Overview

Table 101. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product

Table 102. Shimadzu Corporation Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Shimadzu Corporation Recent Developments

Table 104. Merck & Co. Company Details

Table 105. Merck & Co. Business Overview

Table 106. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product

Table 107. Merck & Co. Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Merck & Co. Recent Developments

Table 109. AstraZeneca Company Details

Table 110. AstraZeneca Business Overview

Table 111. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product

Table 112. AstraZeneca Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 113. AstraZeneca Recent Developments

Table 114. Bristol Myer Squibb Company Details

Table 115. Bristol Myer Squibb Business Overview

Table 116. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product

Table 117. Bristol Myer Squibb Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 118. Bristol Myer Squibb Recent Developments

Table 119. Novartis Company Details

Table 120. Novartis Business Overview

Table 121. Novartis Brain Tumor Diagnosis and Therapeutics Product

Table 122. Novartis Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 123. Novartis Recent Developments

Table 124. Roche Diagnostics Company Details

Table 125. Roche Diagnostics Business Overview

Table 126. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product

Table 127. Roche Diagnostics Revenue in Brain Tumor Diagnosis and Therapeutics Business (2019-2024) & (US$ Million)

Table 128. Roche Diagnostics Recent Developments

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. MRI Features

Figure 4. CT Scan Features

Figure 5. Tissue Sampling Features

Figure 6. PET-CT Scan Features

Figure 7. Cerebral Arteriogram Features

Figure 8. Lumbar Puncture Features

Figure 9. Molecular Testing Features

Figure 10. EEG Features

Figure 11. Global Brain Tumor Diagnosis and Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 12. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application: 2023 VS 2030

Figure 13. Surgery Case Studies

Figure 14. Radiation Therapy Case Studies

Figure 15. Chemotherapy Case Studies

Figure 16. Immunotherapy Case Studies

Figure 17. Targeted Therapy Case Studies

Figure 18. Brain Tumor Diagnosis and Therapeutics Report Years Considered

Figure 19. Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 20. Global Brain Tumor Diagnosis and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 21. Global Brain Tumor Diagnosis and Therapeutics Market Share by Region: 2023 VS 2030

Figure 22. Global Brain Tumor Diagnosis and Therapeutics Market Share by Players in 2023

Figure 23. Global Top Brain Tumor Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2023)

Figure 24. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2023

Figure 25. North America Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. North America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

Figure 27. North America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

Figure 28. North America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)

Figure 29. United States Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Canada Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Europe Brain Tumor Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 32. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

Figure 33. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

Figure 34. Europe Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)

Figure 35. Germany Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. France Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. U.K. Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Italy Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Russia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Nordic Countries Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Brain Tumor Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 42. China Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

Figure 43. China Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

Figure 44. Asia Brain Tumor Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 45. Asia Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

Figure 46. Asia Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

Figure 47. Asia Brain Tumor Diagnosis and Therapeutics Market Share by Region (2019-2030)

Figure 48. Japan Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. South Korea Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. China Taiwan Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. India Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Australia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 55. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Type (2019-2030)

Figure 56. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2030)

Figure 57. Middle East, Africa, and Latin America Brain Tumor Diagnosis and Therapeutics Market Share by Country (2019-2030)

Figure 58. Brazil Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Mexico Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Turkey Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. Israel Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 63. GCC Countries Brain Tumor Diagnosis and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 64. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 65. Hitachi Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 66. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 67. Siemens Healthineers Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 68. Toshiba Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 69. Fujifilm Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 70. Shimadzu Corporation Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 71. Merck & Co. Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 72. AstraZeneca Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 73. Bristol Myer Squibb Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 74. Novartis Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 75. Roche Diagnostics Revenue Growth Rate in Brain Tumor Diagnosis and Therapeutics Business (2019-2024)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37I14671

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G18542

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1A14903

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Brain Tumor Diagnosis and Therapeutics Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-38G13549

Global Brain Tumor Diagnosis and Therapeutics Market Insights, Forecast to 2030

FEATURED COMPANIES

Brain Tumor Diagnosis and Therapeutics Market Size

Brain Tumor Diagnosis and Therapeutics Market

Scope of Brain Tumor Diagnosis and Therapeutics Market Report

Chapter Outline

FAQ for this report

How fast is Brain Tumor Diagnosis and Therapeutics Market growing?

What is the Brain Tumor Diagnosis and Therapeutics Market size in 2030?

Who are the main players in the Brain Tumor Diagnosis and Therapeutics Market report?

What are the Application segmentation covered in the Brain Tumor Diagnosis and Therapeutics Market report?

What are the Type segmentation covered in the Brain Tumor Diagnosis and Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS